中国财富网讯近日,GE医疗发布了应用于脑部、神经系统检查的高端科研型磁共振产品SIGNA MAGNUS。GE医疗中国副总裁、医学影像业务总经理陈金雷表示,SIGNA MAGNUS可把脑部磁共振成像从“用放大镜看”变革到“用显微镜看”的时代,提高脑部微结构和病变的检出能力,为脑损伤、脑肿瘤以及神经退行性等疾病的临床诊疗能力和脑科学关键问题的攻关带来全新方案。此外,GE医疗还发布了SIGNA Pilot凌云3.0T“读秒成像”磁共振产品,减少生理运动带来的图像伪影。
磁共振作为目前可以提供活体实时成像的设备,是提高脑疾病临床诊断评估以及脑部疾病机理研究能力的关键。据GE医疗全球磁共振研发团队所述,与当前临床全身型磁共振相比,相同梯度电流下,SIGNA MAGNUS可进行更加精准、快速、敏感的脑部微结构细节捕捉。
GE医疗全球磁共振研发团队表示,SIGNA MAGNUS凭借微米级的成像能力,可助力脑科学临床研究。同时,SIGNA MAGNUS将以大脑深度研究为起点,通过微小的大脑改变与全身如胃肠、呼吸、心脏、肾脏等各器官的生物指征进行协同研究,将有力加速脑科学临床研究乃至全身的系统性拓展。
(文章来源:中国财富网)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.